SAB Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 02/13/2026 | 11.42 M | $42.71 M | 0.00% | 107.12% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 4.40 M | $16.46 M | 0.00% | 41.29% |
| COMMODORE CAPITAL LP | 02/17/2026 | 4.40 M | $16.46 M | 0.00% | 41.29% |
| WOODLINE PARTNERS LP | 02/17/2026 | 2.85 M | $10.66 M | 0.00% | 26.74% |
| 02/13/2026 | 2.20 M | $8.22 M | 100.00% | 20.62% | |
| SESSA CAPITAL IM, L.P. | 02/17/2026 | 2.20 M | $8.22 M | 0.00% | 20.62% |
| BLACKSTONE INC. | 02/17/2026 | 2.14 M | $8.02 M | 100.00% | 20.11% |
| VANGUARD GROUP INC | 01/29/2026 | 1.85 M | $6.91 M | 405.02% | 17.33% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 803.21 K | $3.00 M | 100.00% | 7.53% |
| PROPEL BIO MANAGEMENT, LLC | 02/11/2026 | 652.88 K | $2.44 M | 100.00% | 6.12% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 580.33 K | $2.17 M | 100.00% | 5.44% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 475.44 K | $1.78 M | 100.00% | 4.46% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 324.09 K | $1.21 M | 100.00% | 3.04% |
| HB WEALTH MANAGEMENT, LLC | 01/28/2026 | 307.50 K | $1.15 M | 0.00% | 2.88% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 283.65 K | $1.06 M | 100.00% | 2.66% |
| MARSHALL WACE, LLP | 02/13/2026 | 236.46 K | $884.36 K | 100.00% | 2.22% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/09/2026 | 208.23 K | $778.77 K | 100.00% | 1.95% |
| AWM INVESTMENT COMPANY, INC. | 02/13/2026 | 200.00 K | $748.00 K | 0.00% | 1.88% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 146.56 K | $548.13 K | 100.00% | 1.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 119.52 K | $447.04 K | 39.43% | 1.12% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 86.11 K | $322.06 K | 100.00% | 0.81% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 51.35 K | $192.04 K | 357.61% | 0.48% |
| PATHSTONE HOLDINGS, LLC | 02/13/2026 | 50.65 K | $189.43 K | 0.00% | 0.48% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 42.00 K | $157.08 K | 100.00% | 0.39% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 31.15 K | $116.49 K | 100.00% | 0.29% |
| CITIGROUP INC | 02/13/2026 | 29.97 K | $112.10 K | 3,502.64% | 0.28% |
| VERITION FUND MANAGEMENT LLC | 02/13/2026 | 26.87 K | $100.48 K | 100.00% | 0.25% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 26.34 K | $98.53 K | 75.63% | 0.25% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 19.79 K | $74.02 K | 100.00% | 0.19% |
| COLONY GROUP, LLC | 02/13/2026 | 19.20 K | $71.81 K | 100.00% | 0.18% |
| FIRST PREMIER BANK | 01/23/2026 | 18.99 K | $71.00 K | 0.00% | 0.18% |
| CITADEL ADVISORS LLC | 02/17/2026 | 17.65 K | $66.01 K | 100.00% | 0.17% |
| BLACKROCK, INC. | 02/12/2026 | 17.24 K | $64.47 K | 171.95% | 0.16% |
| NORTHERN TRUST CORP | 02/17/2026 | 16.41 K | $61.38 K | 44.13% | 0.15% |
| FIFTH LANE CAPITAL, LP | 02/13/2026 | 15.00 K | $56.10 K | 100.00% | 0.14% |
| STATE STREET CORP | 02/13/2026 | 13.12 K | $49.08 K | 100.00% | 0.12% |
| KESTRA ADVISORY SERVICES, LLC | 02/13/2026 | 11.55 K | $43.20 K | -3.19% | 0.11% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 10.61 K | $39.69 K | 14,241.89% | 0.10% |
| CAXTON CORP | 02/13/2026 | 10.53 K | $39.37 K | -3.73% | 0.10% |
| STATE OF WYOMING | 02/11/2026 | 8.97 K | $33.55 K | 100.00% | 0.08% |
| UBS GROUP AG | 01/29/2026 | 7.40 K | $27.67 K | -44.04% | 0.07% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 5.02 K | $18.79 K | 4.15% | 0.05% |
| MORGAN STANLEY | 02/13/2026 | 4.26 K | $15.94 K | 2,436.90% | 0.04% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.99 K | $7.44 K | 2,187.36% | 0.02% |
| MAI CAPITAL MANAGEMENT | 02/13/2026 | 217 | $812 | 0.00% | 0.00% |
| GS INVESTMENTS, INC. | 02/09/2026 | 200 | $748 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/09/2026 | 50 | $187 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 50 | $187 | -3.85% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
SAB Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 63 institutional investors and hedge funds held shares of SAB Biotherapeutics Inc. The most heavily invested institutionals were:
HB Wealth Management, LLC: 307,500
Simplify Asset Management Inc.: 187,230
Kestra Advisory Services, LLC: 61,741
UBS Group AG: 46,623
COMMONWEALTH EQUITY SERVICES, LLC: 46,455
First PREMIER Bank: 18,986
340.90% of SAB Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 35.33 M shares in the last 24 months. This purchase volume represents approximately $135.68 M in transactions.